Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases is a research paper published in Clinical Gastroenterology and Hepatology (2022). On theSindex it has a DataRank of 0.542. It has been cited 36 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Janssen Pharmaceuticals
Northwestern University
Bristol-Myers Squibb
California Community Foundation
Pfizer
Celgene
Division of Gastroenterology and Hepatology, School of Medicine, Indiana University
Kenneth Rainin Foundation
Perelman School of Medicine, University of Pennsylvania
Boehringer Ingelheim
Mayo Clinic
Genentech
National Institutes of Health
University of North Carolina at Chapel Hill
Children's Hospital of Philadelphia
Crohn's and Colitis Foundation
Eli Lilly and Company
GlaxoSmithKline
Leona M. and Harry B. Helmsley Charitable Trust
Takeda Pharmaceuticals U.S.A.
AbbVie
Gilead Sciences
FWCI
3.48
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals